Monday, March 02, 2015 3:58:13 PM
Just a few actions I consider major due to lack of time for searching at the moment:
9.9.13 http://cellceutix.com/cellceutix-acquires-polymedix-assets-from-bankruptcy-court-gains-ownership-of-two-clinical-stage-drugs-multiple-compounds-and-equipment-assets/#sthash.erUO8KJH.dpbs
$CTIX acted quickly on the new acquisitions. They have already completed a phase 2b trial on the newly acquired Brilacidin.
1.5.15 http://cellceutix.com/cellceutix-releases-confidence-interval-statistics-showing-clinical-success-rates-for-brilacidin-in-treatment-of-absssi/#sthash.7LAhMbZr.dpbs
Current trials: https://clinicaltrials.gov/ct2/results?term=cellceutix
Look at the portfolio of drugs: http://cellceutix.com/pipeline/#sthash.d0XjEoxn.dpbs
Look at the chart:
In Reply to 'TimetoRetire'
Too much hype with extremely little follow through in the last couple years.I think Leo is starting to be laughed at by the majority of onlookers including FDA,big Pharma and institutions that may be looking. He has put out too many meaningless pr's and everyone is getting numb to it. I have a lot of money tied up in this company and starting to wonder if Leo is just a super hero in his own eyes. Today's Pr was basically pathetic when he knows his company will be chewed up and spit out unless he gets his act together. This Pr was about something that may happen 3 years out. What about the important stuff that everyone has been essentially promised for the last 3 years Leo? Sorry guys, this is the truth wether it wants to be heard or not. ..
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM